Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets (2023)
Carapeto, Gustavo Vaiano 
; Duque, Marcelo Dutra ; Issa, Michele Georges ; Ferraz, Humberto Gomes
Source: Pharmaceutics. Unidade: FCF
Subjects: MEDICAMENTO GENÉRICO, BIOEQUIVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARAPETO, Gustavo Vaiano et al. Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets. Pharmaceutics, v. 15, p. 1-14 art. 1544, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15051544. Acesso em: 13 ago. 2024.APA
Carapeto, G. V., Duque, M. D., Issa, M. G., & Ferraz, H. G. (2023). Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets. Pharmaceutics, 15, 1-14 art. 1544. doi:10.3390/pharmaceutics15051544NLM
Carapeto GV, Duque MD, Issa MG, Ferraz HG. Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets [Internet]. Pharmaceutics. 2023 ; 15 1-14 art. 1544.[citado 2024 ago. 13 ] Available from: https://doi.org/10.3390/pharmaceutics15051544Vancouver
Carapeto GV, Duque MD, Issa MG, Ferraz HG. Development of Biopredictive dissolution method for extended-release Desvenlafaxine tablets [Internet]. Pharmaceutics. 2023 ; 15 1-14 art. 1544.[citado 2024 ago. 13 ] Available from: https://doi.org/10.3390/pharmaceutics15051544
